{"transactions":[{"id":4639695,"issuer":{"id":8251,"kind":"organization","name":"Cadrenal Therapeutics, Inc.","symbol":"CVKD"},"owners":[{"id":55654,"kind":"person","name":"WILSON GLYNN","position":1,"cik":"0001405625","reported_name":"WILSON GLYNN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2026-10-13T21:30:25.000Z","date":"2026-10-09","kind":"grant","planned":false,"acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The stock options have a grant date of October 9, 2026 under the Issuer's 2022 Successor Equity Incentive Plan, were fully vested and immediately exercisable on the date of grant, and have an exercise price equal to the closing price of the Issuer's common stock on October 9, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options have a grant date of October 9, 2026 under the Issuer's 2022 Successor Equity Incentive Plan, were fully vested and immediately exercisable on the date of grant, and have an exercise price equal to the closing price of the Issuer's common stock on October 9, 2026."}],"balance_after":75000,"derivative":{"exercise_price":0.91,"exercise_date":"2026-10-09","expiration_date":"2036-10-08","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001213900-26-109124","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1937993/000121390026109124/ownership.xml","form_type":"4"}},{"id":826572,"issuer":{"id":7825,"kind":"organization","name":"Caring Brands, Inc.","symbol":"CABR"},"owners":[{"id":55654,"kind":"person","name":"WILSON GLYNN","position":1,"cik":"0001405625","reported_name":"WILSON GLYNN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-03-27T22:56:31.000Z","date":"2026-03-27","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1500000,"price":0.5,"value":750000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents redemption of 1,500,000 shares of common stock of the Issuer at approximately $0.50 per share pursuant to that certain Share Redemption Agreement signed by the Reporting Person and the Issuer on March 19, 2026."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The number of shares of common stock beneficially owned following the reported transaction includes Dr. Wilson's ownership of (i) 126,720 restricted stock units of common stock of the Issuer of which zero have vested, (ii) 45,872 restricted stock units of common stock of the Issuer of which zero have vested, and (iii) 500,000 shares of common stock."}],"balance_after":672592,"source":{"system":"sec-edgar","filing":"0001493152-26-013341","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2020737/000149315226013341/ownership.xml","form_type":"4"}},{"id":969746,"issuer":{"id":7825,"kind":"organization","name":"Caring Brands, Inc.","symbol":"CABR"},"owners":[{"id":55654,"kind":"person","name":"WILSON GLYNN","position":1,"cik":"0001405625","reported_name":"WILSON GLYNN","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-12-16T01:51:35.000Z","date":"2025-12-11","kind":"grant","planned":false,"acquired":false,"shares":45872,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"On December 11, 2025, on recommendation of the Compensation Committee of the Board of the Issuer, the Board approved the issuance of 45,872 restricted stock units of common stock of the Issuer, under its equity incentive plan. The RSU shares will fully vest on December 11, 2026. The vesting of shares is subject to Dr. Wilson's continued service with the Company."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The number of shares of common stock beneficially owned following the reported transactions includes Dr. Wilson's ownership of 2,000,000 shares of common stock."}],"balance_after":2172592,"source":{"system":"sec-edgar","filing":"0001493152-25-027838","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2020737/000149315225027838/ownership.xml","form_type":"4"}},{"id":969745,"issuer":{"id":7825,"kind":"organization","name":"Caring Brands, Inc.","symbol":"CABR"},"owners":[{"id":55654,"kind":"person","name":"WILSON GLYNN","position":1,"cik":"0001405625","reported_name":"WILSON GLYNN","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-12-16T01:51:35.000Z","date":"2025-12-11","kind":"grant","planned":false,"acquired":false,"shares":126720,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On December 11, 2025, on recommendation of the Compensation Committee of the Board of Directors (\"Board\") of the Issuer, the Board approved the issuance of 126,720 restricted stock units of common stock of the Issuer, under its equity incentive plan. The RSU shares will fully vest on June 11, 2026. The vesting of shares is subject to Dr. Wilson's continued services with the Company."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The number of shares of common stock beneficially owned following the reported transactions includes Dr. Wilson's ownership of 2,000,000 shares of common stock."}],"balance_after":2126720,"source":{"system":"sec-edgar","filing":"0001493152-25-027838","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2020737/000149315225027838/ownership.xml","form_type":"4"}},{"id":1295504,"issuer":{"id":8251,"kind":"organization","name":"Cadrenal Therapeutics, Inc.","symbol":"CVKD"},"owners":[{"id":55654,"kind":"person","name":"WILSON GLYNN","position":1,"cik":"0001405625","reported_name":"WILSON GLYNN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2025-01-24T18:13:06.000Z","date":"2025-01-23","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These options vest pro rata on a monthly basis over 12 months commencing on February 1, 2025."}],"balance_after":20000,"derivative":{"exercise_price":19.79,"exercise_date":"2025-02-01","expiration_date":"2035-01-22","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001213900-25-006639","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1405625/000121390025006639/ownership.xml","form_type":"4"}},{"id":1591365,"issuer":{"id":8011,"kind":"organization","name":"BONK, INC."},"owners":[{"id":55654,"kind":"person","name":"WILSON GLYNN","position":1,"cik":"0001405625","reported_name":"WILSON GLYNN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Former CSO, Chairman"}}],"security":"Stock Options","published_at":"2024-03-06T17:20:50.000Z","date":"2024-03-01","kind":"disposition_to_issuer","planned":false,"acquired":true,"shares":1900000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The options have an exercise price ranging between $0.84 to $1.30."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The options were disposed of, for an aggregate price of $190,000, under an omnibus agreement entered into by and among the Reporting Person, Jarrett Boon, John Gulyus, Brian John, and Safety Shot, Inc."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The options were disposed of, for an aggregate price of $190,000, under an omnibus agreement entered into by and among the Reporting Person, Jarrett Boon, John Gulyus, Brian John, and Safety Shot, Inc."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The options were disposed of, for an aggregate price of $190,000, under an omnibus agreement entered into by and among the Reporting Person, Jarrett Boon, John Gulyus, Brian John, and Safety Shot, Inc."}],"balance_after":187344,"derivative":{"exercise_date":"2024-03-01","underlying":"Common Stock","underlying_shares":1900000},"source":{"system":"sec-edgar","filing":"0001493152-24-009074","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1405625/000149315224009074/ownership.xml","form_type":"4"}},{"id":1675104,"issuer":{"id":8251,"kind":"organization","name":"Cadrenal Therapeutics, Inc.","symbol":"CVKD"},"owners":[{"id":55654,"kind":"person","name":"WILSON GLYNN","position":1,"cik":"0001405625","reported_name":"WILSON GLYNN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2024-01-19T19:38:47.000Z","date":"2024-01-18","kind":"grant","planned":false,"acquired":true,"shares":70000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These options vest pro rata on a monthly basis over 12 months commencing on February 1, 2024 and vesting fully on January 18, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options vest pro rata on a monthly basis over 12 months commencing on February 1, 2024 and vesting fully on January 18, 2025."}],"balance_after":70000,"derivative":{"exercise_price":0.94,"expiration_date":"2034-01-17","underlying":"Common Stock","underlying_shares":70000},"source":{"system":"sec-edgar","filing":"0001213900-24-004996","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1405625/000121390024004996/ownership.xml","form_type":"4"}},{"id":2047387,"issuer":{"id":8251,"kind":"organization","name":"Cadrenal Therapeutics, Inc.","symbol":"CVKD"},"owners":[{"id":55654,"kind":"person","name":"WILSON GLYNN","position":1,"cik":"0001405625","reported_name":"WILSON GLYNN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Convertible Promissory Note","published_at":"2023-01-24T17:02:29.000Z","date":"2023-01-24","kind":"exercise","acquired":false,"shares":50000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Upon consummation of the initial public offering of Cadrenal Therapeutics, Inc. on January 24, 2023, Dr. Wilson was issued 50,000 shares of common stock pursuant to the conversion of a convertible promissory note in the principal amount of $50,000, based on a conversion price of $1.00 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Upon consummation of the initial public offering of Cadrenal Therapeutics, Inc. on January 24, 2023, Dr. Wilson was issued 50,000 shares of common stock pursuant to the conversion of a convertible promissory note in the principal amount of $50,000, based on a conversion price of $1.00 per share."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Upon consummation of the initial public offering of Cadrenal Therapeutics, Inc. on January 24, 2023, Dr. Wilson was issued 50,000 shares of common stock pursuant to the conversion of a convertible promissory note in the principal amount of $50,000, based on a conversion price of $1.00 per share."}],"balance_after":0,"derivative":{"exercise_price":1,"underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001213900-23-004886","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1405625/000121390023004886/ownership.xml","form_type":"4"}},{"id":2047386,"issuer":{"id":8251,"kind":"organization","name":"Cadrenal Therapeutics, Inc.","symbol":"CVKD"},"owners":[{"id":55654,"kind":"person","name":"WILSON GLYNN","position":1,"cik":"0001405625","reported_name":"WILSON GLYNN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-24T17:02:29.000Z","date":"2023-01-24","kind":"exercise","acquired":true,"shares":50000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Upon consummation of the initial public offering of Cadrenal Therapeutics, Inc. on January 24, 2023, Dr. Wilson was issued 50,000 shares of common stock pursuant to the conversion of a convertible promissory note in the principal amount of $50,000, based on a conversion price of $1.00 per share."}],"balance_after":50000,"source":{"system":"sec-edgar","filing":"0001213900-23-004886","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1405625/000121390023004886/ownership.xml","form_type":"4"}},{"id":2074154,"issuer":{"id":8011,"kind":"organization","name":"BONK, INC."},"owners":[{"id":55654,"kind":"person","name":"WILSON GLYNN","position":1,"cik":"0001405625","reported_name":"WILSON GLYNN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CSO, Chairman"}}],"security":"Stock Options","published_at":"2022-12-30T18:15:11.000Z","date":"2022-12-30","kind":"grant","acquired":true,"shares":1050000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The options are granted under the 2022 Equity Incentive plans, with an exercise price of $0.7600 based on the closing sale price of Company's common stock on December 29, 2022. The options are exercisable within five years from the transaction date herein."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The options are granted under the 2022 Equity Incentive plans, with an exercise price of $0.7600 based on the closing sale price of Company's common stock on December 29, 2022. The options are exercisable within five years from the transaction date herein."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The options are granted under the 2022 Equity Incentive plans, with an exercise price of $0.7600 based on the closing sale price of Company's common stock on December 29, 2022. The options are exercisable within five years from the transaction date herein."}],"balance_after":2236194,"derivative":{"exercise_price":0.76,"exercise_date":"2022-12-30","underlying":"Common Stock","underlying_shares":1050000},"source":{"system":"sec-edgar","filing":"0001493152-22-037199","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1405625/000149315222037199/ownership.xml","form_type":"4"}},{"id":2074153,"issuer":{"id":8011,"kind":"organization","name":"BONK, INC."},"owners":[{"id":55654,"kind":"person","name":"WILSON GLYNN","position":1,"cik":"0001405625","reported_name":"WILSON GLYNN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CSO, Chairman"}}],"security":"Common Stock","published_at":"2022-12-30T18:15:11.000Z","date":"2022-07-26","kind":"disposition_to_issuer","acquired":false,"shares":14124,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The options are granted under the 2022 Equity Incentive plans, with an exercise price of $0.7600 based on the closing sale price of Company's common stock on December 29, 2022. The options are exercisable within five years from the transaction date herein."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The options are granted under the 2022 Equity Incentive plans, with an exercise price of $0.7600 based on the closing sale price of Company's common stock on December 29, 2022. The options are exercisable within five years from the transaction date herein."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The options are granted under the 2022 Equity Incentive plans, with an exercise price of $0.7600 based on the closing sale price of Company's common stock on December 29, 2022. The options are exercisable within five years from the transaction date herein."}],"balance_after":950000,"source":{"system":"sec-edgar","filing":"0001493152-22-037199","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1405625/000149315222037199/ownership.xml","form_type":"4"}},{"id":2201301,"issuer":{"id":8011,"kind":"organization","name":"BONK, INC."},"owners":[{"id":55654,"kind":"person","name":"WILSON GLYNN","position":1,"cik":"0001405625","reported_name":"WILSON GLYNN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CSO, Chairman"}}],"security":"Stock Options","published_at":"2022-07-27T20:42:43.000Z","date":"2022-07-26","kind":"disposition_to_issuer","acquired":true,"shares":2750,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On July 26, 2021 the Reporting Person surrendered 2,750 options to purchases Issuer's common stock and now owns 155,444 options to purchases Issuer's common stock pursuant to the Issuer's 2021 Equity Incentive Plan. On July 26, 2021 the Reporting Person surrendered 14,124 shares of common stock issued to him pursuant to the Issuer's 2021 Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On July 26, 2021 the Reporting Person surrendered 2,750 options to purchases Issuer's common stock and now owns 155,444 options to purchases Issuer's common stock pursuant to the Issuer's 2021 Equity Incentive Plan. On July 26, 2021 the Reporting Person surrendered 14,124 shares of common stock issued to him pursuant to the Issuer's 2021 Equity Incentive Plan."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On July 26, 2021 the Reporting Person surrendered 2,750 options to purchases Issuer's common stock and now owns 155,444 options to purchases Issuer's common stock pursuant to the Issuer's 2021 Equity Incentive Plan. On July 26, 2021 the Reporting Person surrendered 14,124 shares of common stock issued to him pursuant to the Issuer's 2021 Equity Incentive Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"On July 26, 2021 the Reporting Person surrendered 2,750 options to purchases Issuer's common stock and now owns 155,444 options to purchases Issuer's common stock pursuant to the Issuer's 2021 Equity Incentive Plan. On July 26, 2021 the Reporting Person surrendered 14,124 shares of common stock issued to him pursuant to the Issuer's 2021 Equity Incentive Plan."}],"balance_after":1186194,"derivative":{"exercise_price":1.77,"underlying":"Common Stock","underlying_shares":2750},"source":{"system":"sec-edgar","filing":"0001493152-22-020452","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1405625/000149315222020452/ownership.xml","form_type":"4"}},{"id":2201300,"issuer":{"id":8011,"kind":"organization","name":"BONK, INC."},"owners":[{"id":55654,"kind":"person","name":"WILSON GLYNN","position":1,"cik":"0001405625","reported_name":"WILSON GLYNN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CSO, Chairman"}}],"security":"Common Stock","published_at":"2022-07-27T20:42:43.000Z","date":"2022-07-26","kind":"disposition_to_issuer","acquired":false,"shares":14124,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On July 26, 2021 the Reporting Person surrendered 2,750 options to purchases Issuer's common stock and now owns 155,444 options to purchases Issuer's common stock pursuant to the Issuer's 2021 Equity Incentive Plan. On July 26, 2021 the Reporting Person surrendered 14,124 shares of common stock issued to him pursuant to the Issuer's 2021 Equity Incentive Plan."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On July 26, 2021 the Reporting Person surrendered 2,750 options to purchases Issuer's common stock and now owns 155,444 options to purchases Issuer's common stock pursuant to the Issuer's 2021 Equity Incentive Plan. On July 26, 2021 the Reporting Person surrendered 14,124 shares of common stock issued to him pursuant to the Issuer's 2021 Equity Incentive Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"On July 26, 2021 the Reporting Person surrendered 2,750 options to purchases Issuer's common stock and now owns 155,444 options to purchases Issuer's common stock pursuant to the Issuer's 2021 Equity Incentive Plan. On July 26, 2021 the Reporting Person surrendered 14,124 shares of common stock issued to him pursuant to the Issuer's 2021 Equity Incentive Plan."}],"balance_after":950000,"source":{"system":"sec-edgar","filing":"0001493152-22-020452","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1405625/000149315222020452/ownership.xml","form_type":"4"}},{"id":2423929,"issuer":{"id":8011,"kind":"organization","name":"BONK, INC."},"owners":[{"id":55654,"kind":"person","name":"WILSON GLYNN","position":1,"cik":"0001405625","reported_name":"WILSON GLYNN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CSO, Chairman"}}],"security":"Stock Options","published_at":"2022-01-27T21:36:20.000Z","date":"2021-12-06","kind":"grant","acquired":true,"shares":25000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On December 6, 2021, and pursuant to the Issuer's 2021 Incentive Equity Plan, the Reporting Person received options to purchase up to 25,000 shares of the Issuer's common stock, par value $0.001 (the \"Options\"), at an exercise price of $1.41. The Options are exercisable for a period of five years and vested immediately."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On December 6, 2021, and pursuant to the Issuer's 2021 Incentive Equity Plan, the Reporting Person received options to purchase up to 25,000 shares of the Issuer's common stock, par value $0.001 (the \"Options\"), at an exercise price of $1.41. The Options are exercisable for a period of five years and vested immediately."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On November 24, 2021 pursuant to a board resolution the Reporting Person was awarded 1,000,000 options to purchase Issuer's common stock, pursuant to the Issuer's 2021 Equity Incentive Plan. On December 6, 2021, the Reporting Person surrendered 100,000 options and now owns 900,000 options to purchases Issuer's common stock, at an exercise price of $1.41."}],"balance_after":900000,"derivative":{"exercise_price":1.41,"exercise_date":"2021-12-06","expiration_date":"2026-12-05","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001493152-22-002457","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1405625/000149315222002457/ownership.xml","form_type":"4"}},{"id":2493033,"issuer":{"id":8011,"kind":"organization","name":"BONK, INC."},"owners":[{"id":55654,"kind":"person","name":"WILSON GLYNN","position":1,"cik":"0001405625","reported_name":"WILSON GLYNN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CSO, Chairman"}}],"security":"Stock Options","published_at":"2021-11-29T16:30:15.000Z","date":"2021-11-24","kind":"grant","acquired":true,"shares":875000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On November 24, 2021, and pursuant to the Issuer's 2021 Incentive Equity Plan, the Reporting Person received options to purchase up to 875,000 shares of the Issuer's common stock, par value $0.001 (the \"Options\"), at an exercise price of $1.41. The exercise price of the Options was based on the closing price of the Issuer's common stock on the day prior to the grant. The Options are exercisable for a period of five years and vested immediately."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On November 24, 2021, and pursuant to the Issuer's 2021 Incentive Equity Plan, the Reporting Person received options to purchase up to 875,000 shares of the Issuer's common stock, par value $0.001 (the \"Options\"), at an exercise price of $1.41. The exercise price of the Options was based on the closing price of the Issuer's common stock on the day prior to the grant. The Options are exercisable for a period of five years and vested immediately."}],"balance_after":875000,"derivative":{"exercise_price":1.41,"exercise_date":"2021-11-24","expiration_date":"2026-11-24","underlying":"Common Stock","underlying_shares":875000},"source":{"system":"sec-edgar","filing":"0001493152-21-030014","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1405625/000149315221030014/ownership.xml","form_type":"4"}},{"id":2512589,"issuer":{"id":8011,"kind":"organization","name":"BONK, INC."},"owners":[{"id":55654,"kind":"person","name":"WILSON GLYNN","position":1,"cik":"0001405625","reported_name":"WILSON GLYNN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CSO, Chairman"}}],"security":"Common Stock","published_at":"2021-11-15T16:30:56.000Z","date":"2021-11-10","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The shares of common stock were awarded pursuant to the Reporting Peron's Employment Agreement with the Issuer."},{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares of common stock were awarded pursuant to the Reporting Peron's Employment Agreement with the Issuer."},{"field":"shares","element":"transactionShares","label":"F1","text":"The shares of common stock were awarded pursuant to the Reporting Peron's Employment Agreement with the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of common stock were awarded pursuant to the Reporting Peron's Employment Agreement with the Issuer."}],"balance_after":956024,"source":{"system":"sec-edgar","filing":"0001493152-21-028643","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1405625/000149315221028643/ownership.xml","form_type":"4"}},{"id":2597650,"issuer":{"id":8011,"kind":"organization","name":"BONK, INC."},"owners":[{"id":55654,"kind":"person","name":"WILSON GLYNN","position":1,"cik":"0001405625","reported_name":"WILSON GLYNN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CSO, Chairman"}}],"security":"Stock Option","published_at":"2021-08-18T19:17:53.000Z","date":"2021-08-16","kind":"grant","acquired":true,"shares":155444,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F2","text":"The options were issued pursuant to a board resolution dated August 16, 2021 under the 2020 Incentive Equity Plan."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The options were issued pursuant to a board resolution dated August 16, 2021 under the 2020 Incentive Equity Plan."},{"field":"shares","element":"transactionShares","label":"F2","text":"The options were issued pursuant to a board resolution dated August 16, 2021 under the 2020 Incentive Equity Plan."}],"balance_after":911468,"derivative":{"exercise_price":1.77,"exercise_date":"2021-08-16","expiration_date":"2026-08-16","underlying":"Common Stock","underlying_shares":155444},"source":{"system":"sec-edgar","filing":"0001493152-21-020610","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1405625/000149315221020610/ownership.xml","form_type":"4"}},{"id":2597649,"issuer":{"id":8011,"kind":"organization","name":"BONK, INC."},"owners":[{"id":55654,"kind":"person","name":"WILSON GLYNN","position":1,"cik":"0001405625","reported_name":"WILSON GLYNN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CSO, Chairman"}}],"security":"Common Stock","published_at":"2021-08-18T19:17:53.000Z","date":"2021-08-16","kind":"grant","acquired":true,"shares":14124,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The shares of common stock were awarded pursuant to a board resolution dated August 16, 2021 and the 2020 Incentive Equity Plan as a form of compensation."},{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares of common stock were awarded pursuant to a board resolution dated August 16, 2021 and the 2020 Incentive Equity Plan as a form of compensation."},{"field":"shares","element":"transactionShares","label":"F1","text":"The shares of common stock were awarded pursuant to a board resolution dated August 16, 2021 and the 2020 Incentive Equity Plan as a form of compensation."}],"balance_after":756024,"source":{"system":"sec-edgar","filing":"0001493152-21-020610","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1405625/000149315221020610/ownership.xml","form_type":"4"}},{"id":2623745,"issuer":{"id":8011,"kind":"organization","name":"BONK, INC."},"owners":[{"id":55654,"kind":"person","name":"WILSON GLYNN","position":1,"cik":"0001405625","reported_name":"WILSON GLYNN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Common Stock","published_at":"2021-07-27T19:56:40.000Z","date":"2021-07-26","kind":"sale","acquired":false,"shares":50000,"price":2.79,"value":139500.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The shares of common stock were sold pursuant to the Company's underwritten public offering under a registration statement (File Number: 333-258005) filed with the Securities Exchange Commission which became effective on July 21, 2021. The holder paid a fee of $0.23 per share in underwriting fees."},{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares of common stock were sold pursuant to the Company's underwritten public offering under a registration statement (File Number: 333-258005) filed with the Securities Exchange Commission which became effective on July 21, 2021. The holder paid a fee of $0.23 per share in underwriting fees."},{"field":"shares","element":"transactionShares","label":"F1","text":"The shares of common stock were sold pursuant to the Company's underwritten public offering under a registration statement (File Number: 333-258005) filed with the Securities Exchange Commission which became effective on July 21, 2021. The holder paid a fee of $0.23 per share in underwriting fees."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of common stock were sold pursuant to the Company's underwritten public offering under a registration statement (File Number: 333-258005) filed with the Securities Exchange Commission which became effective on July 21, 2021. The holder paid a fee of $0.23 per share in underwriting fees."}],"balance_after":750000,"source":{"system":"sec-edgar","filing":"0001493152-21-017896","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1405625/000149315221017896/ownership.xml","form_type":"4"}},{"id":2644237,"issuer":{"id":8011,"kind":"organization","name":"BONK, INC."},"owners":[{"id":55654,"kind":"person","name":"WILSON GLYNN","position":1,"cik":"0001405625","reported_name":"WILSON GLYNN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Chief Science Officer"}}],"security":"Option","published_at":"2021-07-02T17:23:12.000Z","date":"2021-06-30","kind":"grant","acquired":true,"shares":33500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Derivative securities issued pursuant to company's equity incentive plan."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Derivative securities issued pursuant to company's equity incentive plan."}],"balance_after":33500,"derivative":{"exercise_price":4.48,"exercise_date":"2021-07-01","expiration_date":"2026-06-30","underlying":"Common Stock"},"source":{"system":"sec-edgar","filing":"0001264931-21-000093","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1405625/000126493121000093/ownership.xml","form_type":"4"}},{"id":2927394,"issuer":{"id":8011,"kind":"organization","name":"BONK, INC."},"owners":[{"id":55654,"kind":"person","name":"WILSON GLYNN","position":1,"cik":"0001405625","reported_name":"WILSON GLYNN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-12-31T16:59:16.000Z","date":"2020-12-14","kind":"exercise","acquired":true,"shares":200000,"price":0.25,"value":50000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The 200,000 shares of common stock were issued to Mr. Wilson pursuant to the conversion of a promissory note, dated July 25, 2019."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 300,000 shares of common stock authorized by the board of directors of Jupiter Wellness, Inc. but not yet issued to Mr. Wilson."}],"balance_after":600000,"source":{"system":"sec-edgar","filing":"0001264931-20-000263","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1405625/000126493120000263/ownership.xml","form_type":"4"}},{"id":3793714,"issuer":{"id":7609,"kind":"organization","name":"Marker Therapeutics, Inc."},"owners":[{"id":55654,"kind":"person","name":"WILSON GLYNN","position":1,"cik":"0001405625","reported_name":"WILSON GLYNN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Employment Agreement (right to receive)","published_at":"2018-10-10T20:50:47.000Z","date":"2018-10-09","kind":"exercise","acquired":false,"shares":31120,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Represents elimination of Reporting Person's right to receive shares under his employment agreement following the issuance of the shares to the Reporting Person reflected on Table I by the Company."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents elimination of Reporting Person's right to receive shares under his employment agreement following the issuance of the shares to the Reporting Person reflected on Table I by the Company."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Represents elimination of Reporting Person's right to receive shares under his employment agreement following the issuance of the shares to the Reporting Person reflected on Table I by the Company."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":31120},"source":{"system":"sec-edgar","filing":"0001144204-18-053247","document":"tv504612_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1094038/000114420418053247/tv504612_4.xml","form_type":"4"}},{"id":3793713,"issuer":{"id":7609,"kind":"organization","name":"Marker Therapeutics, Inc."},"owners":[{"id":55654,"kind":"person","name":"WILSON GLYNN","position":1,"cik":"0001405625","reported_name":"WILSON GLYNN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-10-10T20:50:47.000Z","date":"2018-10-09","kind":"tax_withholding","acquired":false,"shares":7561,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents withholding of shares of common stock to satisfy tax withholding obligations in connection with the issuance of the stock award."}],"balance_after":181776,"source":{"system":"sec-edgar","filing":"0001144204-18-053247","document":"tv504612_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1094038/000114420418053247/tv504612_4.xml","form_type":"4"}},{"id":3793712,"issuer":{"id":7609,"kind":"organization","name":"Marker Therapeutics, Inc."},"owners":[{"id":55654,"kind":"person","name":"WILSON GLYNN","position":1,"cik":"0001405625","reported_name":"WILSON GLYNN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-10-10T20:50:47.000Z","date":"2018-10-09","kind":"grant","acquired":true,"shares":31120,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents issuance of fully vested shares of common stock under the Company's 2014 Omnibus Stock Ownership Plan pursuant to the Company's obligation to do so under the terms of the Reporting Person's employment agreement as amended."}],"balance_after":189337,"source":{"system":"sec-edgar","filing":"0001144204-18-053247","document":"tv504612_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1094038/000114420418053247/tv504612_4.xml","form_type":"4"}},{"id":3808510,"issuer":{"id":7609,"kind":"organization","name":"Marker Therapeutics, Inc."},"owners":[{"id":55654,"kind":"person","name":"WILSON GLYNN","position":1,"cik":"0001405625","reported_name":"WILSON GLYNN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-09-25T21:03:09.000Z","date":"2018-09-22","kind":"grant","acquired":true,"shares":31120,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents the number of shares of restricted stock the reporting person has a present right to receive under the terms of the amendment to his employment agreement with the Company, and such shares are based on a value of $300,000 and the closing price of the Company's common stock on September 21, 2018 of $9.64 per share, (which was the date immediately preceding the anniversary of the amendment) and upon issuance under the Company's 2014 Omnibus Stock Ownership Plan to be fully vested."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the number of shares of restricted stock the reporting person has a present right to receive under the terms of the amendment to his employment agreement with the Company, and such shares are based on a value of $300,000 and the closing price of the Company's common stock on September 21, 2018 of $9.64 per share, (which was the date immediately preceding the anniversary of the amendment) and upon issuance under the Company's 2014 Omnibus Stock Ownership Plan to be fully vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents the number of shares of restricted stock the reporting person has a present right to receive under the terms of the amendment to his employment agreement with the Company, and such shares are based on a value of $300,000 and the closing price of the Company's common stock on September 21, 2018 of $9.64 per share, (which was the date immediately preceding the anniversary of the amendment) and upon issuance under the Company's 2014 Omnibus Stock Ownership Plan to be fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Represents the number of shares of restricted stock the reporting person has a present right to receive under the terms of the amendment to his employment agreement with the Company, and such shares are based on a value of $300,000 and the closing price of the Company's common stock on September 21, 2018 of $9.64 per share, (which was the date immediately preceding the anniversary of the amendment) and upon issuance under the Company's 2014 Omnibus Stock Ownership Plan to be fully vested."}],"balance_after":31120,"derivative":{"underlying":"Common Stock","underlying_shares":31120},"source":{"system":"sec-edgar","filing":"0001144204-18-050737","document":"tv503493_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1094038/000114420418050737/tv503493_4.xml","form_type":"4"}},{"id":4201779,"issuer":{"id":7609,"kind":"organization","name":"Marker Therapeutics, Inc."},"owners":[{"id":55654,"kind":"person","name":"WILSON GLYNN","position":1,"cik":"0001405625","reported_name":"WILSON GLYNN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-09-26T20:05:22.000Z","date":"2017-09-22","kind":"tax_withholding","acquired":false,"shares":27350,"price":3.18,"value":86973.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents withholding of shares of common stock to satisfy tax withholding obligations in connection with the issuance of the restricted stock award."}],"balance_after":158217,"source":{"system":"sec-edgar","filing":"0001144204-17-049725","document":"v475881_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1094038/000114420417049725/v475881_4.xml","form_type":"4"}},{"id":4201778,"issuer":{"id":7609,"kind":"organization","name":"Marker Therapeutics, Inc."},"owners":[{"id":55654,"kind":"person","name":"WILSON GLYNN","position":1,"cik":"0001405625","reported_name":"WILSON GLYNN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-09-26T20:05:22.000Z","date":"2017-09-22","kind":"grant","acquired":true,"shares":100000,"price":3.18,"value":318000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of fully vested restricted stock issued under the Company's 2014 Omnibus Stock Ownership Plan in connection with the execution of amendment to employment agreement reflecting change in status from President and Chief Executive Officer to Strategic Advisor."}],"balance_after":185567,"source":{"system":"sec-edgar","filing":"0001144204-17-049725","document":"v475881_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1094038/000114420417049725/v475881_4.xml","form_type":"4"}},{"id":4389362,"issuer":{"id":7609,"kind":"organization","name":"Marker Therapeutics, Inc."},"owners":[{"id":55654,"kind":"person","name":"WILSON GLYNN","position":1,"cik":"0001405625","reported_name":"WILSON GLYNN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2017-03-13T20:02:02.000Z","date":"2017-03-09","kind":"grant","acquired":true,"shares":12761,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the portion of a discretionary bonus award for 2016 payable as a restricted, immediately vested, common stock under the Company's 2014 Omnibus Stock Ownership Plan. The issuance of 12,761 shares of restricted common stock was based on the closing price or our common stock of $4.31 per share, on the day immediately preceding the date the 2016 bonus award was approved."}],"balance_after":85567,"source":{"system":"sec-edgar","filing":"0001144204-17-014235","document":"v461697_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1094038/000114420417014235/v461697_4.xml","form_type":"4"}}]}